|
|
Volumn 1, Issue 1, 2012, Pages 3-5
|
|
A new paradigm for funding medical research
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATOMIC BOMB;
CHRONIC DISEASE;
FUNDING;
HEALTH CARE COST;
HEALTH CARE SYSTEM;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PEER REVIEW;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
REGENERATIVE MEDICINE;
RISK REDUCTION;
SCIENTIST;
STEM CELL RESEARCH;
STEM CELL TRANSPLANTATION;
ANIMAL;
ARTICLE;
ECONOMICS;
FINANCIAL MANAGEMENT;
GOVERNMENT REGULATION;
HEALTH CARE POLICY;
LEGAL ASPECT;
MEDICAL RESEARCH;
NONBIOLOGICAL MODEL;
ORGANIZATION AND MANAGEMENT;
UNITED STATES;
ANIMALS;
BIOMEDICAL RESEARCH;
FINANCING, GOVERNMENT;
GOVERNMENT REGULATION;
HEALTH POLICY;
HUMANS;
MODELS, ORGANIZATIONAL;
RESEARCH SUPPORT AS TOPIC;
UNITED STATES;
|
|
EID: 84872035462
PISSN: 21576564
EISSN: 21576580
Source Type: Journal
DOI: 10.5966/sctm.2011-0049 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
